A share price of Structure Therapeutics Inc ADR [GPCR] is currently trading at $39.64, up 15.17%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GPCR shares have gain 4.67% over the last week, with a monthly amount glided 19.47%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Structure Therapeutics Inc ADR [NASDAQ: GPCR] stock has seen the most recent analyst activity on May 21, 2024, when JP Morgan initiated its Overweight rating and assigned the stock a price target of $65. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on April 09, 2024, and set its price target to $65. On October 19, 2023, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $90 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $58 on July 27, 2023. SVB Securities started tracking with a Outperform rating for this stock on February 28, 2023, and assigned it a price target of $33. In a note dated February 28, 2023, Jefferies initiated an Buy rating and provided a target price of $34 on this stock.
Structure Therapeutics Inc ADR experienced fluctuations in its stock price throughout the past year between $26.61 and $75.02. Currently, Wall Street analysts expect the stock to reach $86 within the next 12 months. Structure Therapeutics Inc ADR [NASDAQ: GPCR] shares were valued at $39.64 at the most recent close of the market. An investor can expect a potential return of 116.95% based on the average GPCR price forecast.
Analyzing the GPCR fundamentals
Gross Profit Margin for this corporation currently stands at -0.14% with Operating Profit Margin at -92.22%, Pretax Profit Margin comes in at -75.49%, and Net Profit Margin reading is -75.62%. To continue investigating profitability, this company’s Return on Assets is posted at -0.11, Equity is -0.2 and Total Capital is -0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 35.84 points at the first support level, and at 32.04 for the second support level. However, for the 1st resistance point, the stock is sitting at 41.83, and for the 2nd resistance point, it is at 44.02.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Structure Therapeutics Inc ADR [NASDAQ:GPCR] is 41.38. In addition, the Quick Ratio stands at 41.38 and the Cash Ratio stands at 16.84.
